Evidence map›Paper›PMID 28392260›Full record

ArticleStructure (London, England : 1993)2017

Hybrid Mass Spectrometry Approaches to Determine How L-Histidine Feedback Regulates the Enzyzme MtATP-Phosphoribosyltransferase.

Kamila J Pacholarz, Rebecca J Burnley, Thomas A Jowitt, Victoria Ordsmith, João Pedro Pisco, Massimiliano Porrini, Gérald Larrouy-Maumus, Rachel A Garlish, Richard J Taylor, Luiz Pedro Sório de Carvalho and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Structure (London, England : 1993), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Kamila J PacholarzMichael Barber Centre for Collaborative Mass Spectrometry, Manchester Institute of Biotechnology, School of Chemistry, 131 Princess Street, Manchester M1 7DN, UK; School of Chemistry, University of Edinburgh, David Brewster Road, Edinburgh EH9 3FJ, UK.
Rebecca J BurnleyUCB Celltech, 216 Bath Road, Slough SL1 3WE, UK.
Thomas A JowittThe Biomolecular Analysis Facility, Faculty of Life Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, UK.
Victoria OrdsmithSchool of Chemistry, University of Edinburgh, David Brewster Road, Edinburgh EH9 3FJ, UK.
João Pedro PiscoMycobacterial Metabolism and Antibiotic Research Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
Massimiliano PorriniSchool of Chemistry, University of Edinburgh, David Brewster Road, Edinburgh EH9 3FJ, UK.
Gérald Larrouy-MaumusMycobacterial Metabolism and Antibiotic Research Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
Rachel A GarlishUCB Celltech, 216 Bath Road, Slough SL1 3WE, UK.
Richard J TaylorUCB Celltech, 216 Bath Road, Slough SL1 3WE, UK.
Luiz Pedro Sório de CarvalhoMycobacterial Metabolism and Antibiotic Research Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK. Electronic address: luiz.carvalho@crick.ac.uk.
Perdita E BarranMichael Barber Centre for Collaborative Mass Spectrometry, Manchester Institute of Biotechnology, School of Chemistry, 131 Princess Street, Manchester M1 7DN, UK. Electronic address: perdita.barran@manchester.ac.uk.
The Francis Crick Institute · GBUCB Pharma (United Kingdom) · GBUniversity of Manchester · GBUniversity of Edinburgh · GB

Funding

Biotechnology and Biological Sciences Research Council BB/H013636/1Biotechnology and Biological Sciences Research Council BB/L015048/1Biotechnology and Biological Sciences Research Council BB/M017702/1Medical Research Council MR/J006874/1Wellcome Trust
6 · The paper itself

Abstract

MtATP-phosphoribosyltransferase (MtATP-PRT) is an enzyme catalyzing the first step of the biosynthesis of L-histidine in Mycobacterium tuberculosis, and proposed to be regulated via an allosteric mechanism. Native mass spectrometry (MS) reveals MtATP-PRT to exist as a hexamer. Conformational changes induced by L-histidine binding and the influence of buffer pH are determined with ion mobility MS, hydrogen deuterium exchange (HDX) MS, and analytical ultracentrifugation. The experimental collision cross-section (

Indexed as

Allosteric SiteAllosteric RegulationATP PhosphoribosyltransferaseBacterial ProteinsFeedback, PhysiologicalHistidineMass SpectrometryMycobacterium tuberculosisProtein BindingATP PhosphoribosyltransferaseBacterial ProteinsHistidineallosteryATP-phosphoribosyltransferasehydrogen deuterium exchangeion mobilityprotein conformationstructural mass spectrometrytuberculosis

Identifiers

PMID28392260
PMCPMC5415358
OpenAlexW2604438638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.